<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-57150" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Double-Blind Study</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>David</surname>
            <given-names>Sharoon</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khandhar</surname>
            <given-names>Paras B.</given-names>
          </name>
          <aff>Beaumont Health System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sharoon David declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Paras Khandhar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-57150.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">A clinical research study or a clinical trial is an experiment or observation performed on human subjects to generate data on the safety and efficacy of various biomedical and behavioral interventions.<xref ref-type="bibr" rid="article-57150.r1">[1]</xref></p>
        <p>Blinding or masking refers to the withholding of information regarding treatment allocation from one or more participants in a clinical research study. It is an essential methodological feature of clinical studies that help maximize the validity of the research results.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="31046453">[2]</ext-link></p>
      </sec>
      <sec id="article-57150.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Blinding covers any of the numerous participants of the clinical trial, e.g., researchers, subjects, technicians, and data analysts. Single-, double-, and triple-blinding are commonly used blinding strategies in clinical research. A single-blind study masks the subjects from knowing which study treatment, if any, they are receiving. A double-blind study blinds both the subjects as well as the researchers to the treatment allocation. Triple-blinding involves withholding this information from the patients, researchers, as well as data analysts.Randomized, double-blind placebo-controlled trials involve the random&#x000a0;placement of participants into two groups; an experimental group that receives the investigational treatment and a control group that acquires a placebo. Neither the researchers nor the study subjects know who is getting the experimental treatment and who is getting a placebo. This type of clinical study ranks as the gold standard for the validation of treatment interventions.<xref ref-type="bibr" rid="article-57150.r2">[3]</xref></p>
        <p>Unfortunately, blinding is not possible to achieve in all clinical trials. For example, the method of drug delivery may not be amenable to blinding. An excellent clinical protocol may help ensure that within the ethical and practical constraints, blinding is achieved as effectively as possible.</p>
      </sec>
      <sec id="article-57150.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Bias refers to a deviation from the truth in the collection, analysis, interpretation, or publication of data, leading to false conclusions. Poor blinding of a clinical research study may lead to bias that may result in inflated effect size and increase the risk of type I error. Even a small error in blinding may lead to a statistically significant result without any real difference between the study groups.<xref ref-type="bibr" rid="article-57150.r3">[4]</xref></p>
        <p>Keeping both the researchers and the subjects blinded to treatment allows a double-blinded study to prevent the researchers from treating the study groups differently. The double-blinded study minimizes the risk of various types of biases, such as observer bias or confirmation bias, which&#x000a0;may influence&#x000a0;the results of the investigation.<xref ref-type="bibr" rid="article-57150.r4">[5]</xref><xref ref-type="bibr" rid="article-57150.r5">[6]</xref>&#x000a0;It may also help avoid a disproportionately large placebo effect in the patients involved in the study.<xref ref-type="bibr" rid="article-57150.r2">[3]</xref></p>
        <p>Unblinding may occur during any portion of the blinded clinical trial. Unblinding that occurs before the conclusion of a trial may be a source of bias that the study should document and report. It is the responsibility of all the healthcare professionals involved in a clinical trial, such as physicians, nurses, pharmacists, technicians, and data analysts, to maintain blinding as effectively as possible during the trial and to report any premature unblinding.<xref ref-type="bibr" rid="article-57150.r6">[7]</xref></p>
      </sec>
      <sec id="article-57150.s4">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=57150&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=57150">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/57150/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=57150">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-57150.s5">
        <title>References</title>
        <ref id="article-57150.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ranganathan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Study designs: Part 1 - An overview and classification.</article-title>
            <source>Perspect Clin Res</source>
            <year>2018</year>
            <season>Oct-Dec</season>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>184</fpage>
            <page-range>184-186</page-range>
            <pub-id pub-id-type="pmid">30319950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57150.r2">
          <label>2</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Munnangi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sundjaja</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dua</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <chapter-title>Placebo Effect</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>11</month>
            <day>13</day>
            <pub-id pub-id-type="pmid">30020668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57150.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Probst</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zaschke</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Heger</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Harnoss</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>H&#x000fc;ttner</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Mihaljevic</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Knebel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Diener</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Evidence-based recommendations for blinding in surgical trials.</article-title>
            <source>Langenbecks Arch Surg</source>
            <year>2019</year>
            <month>May</month>
            <volume>404</volume>
            <issue>3</issue>
            <fpage>273</fpage>
            <page-range>273-284</page-range>
            <pub-id pub-id-type="pmid">30824993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57150.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Quan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Clinical Trials Focusing on Drug Control and Prevention of Ventilator-Associated Pneumonia: A Comprehensive Analysis of Trials Registered on ClinicalTrials.gov.</article-title>
            <source>Front Pharmacol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>1574</fpage>
            <pub-id pub-id-type="pmid">30863312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57150.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Platt</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Platt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Klungel</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Suissa</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias.</article-title>
            <source>Pharmacoepidemiol Drug Saf</source>
            <year>2019</year>
            <month>Jan</month>
            <day>15</day>
            <pub-id pub-id-type="pmid">30648307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57150.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clifton</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Clifton</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>How to maintain the maximal level of blinding in randomisation for a placebo-controlled drug trial.</article-title>
            <source>Contemp Clin Trials Commun</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>14</volume>
            <fpage>100356</fpage>
            <pub-id pub-id-type="pmid">31011659</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
